Genetically engineered mice: A new paradigm to study gastric physiology

Current Opinion in Gastroenterology

Volumn 23, Issue 6, 2007, Pages 602-606

  Chen, Duan ^a,b   Zhao, Chun Mei ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Acid secretion; Gastrin; Ghrelin; Knockout mice; Obestatin; Stomach

Indexed keywords

CHOLECYSTOKININ; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; GASTRIN; GHRELIN; HISTAMINE; OBESTATIN; PROTEIN; SOMATOSTATIN; UNCLASSIFIED DRUG; ZINC;

GENETIC ANALYSIS; GENETIC ENGINEERING; KNOCKOUT MOUSE; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PROTEIN INTERACTION; REVIEW; STOMACH ACID SECRETION;

ANIMALS; GASTRIC ACID; GHRELIN; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; PARIETAL CELLS, GASTRIC; STOMACH;

EID: 34848904214     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282f01dbd     Document Type: Review

References (55)

1. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141:4255-4261.
2. Dornonville de la Cour C, Björkqvist M, Sandvik AK, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 2001; 99:141-150.
3. Rindi G, Necchi V, Savio A, et al. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol 2002; 117:511-519.
4. Dun SL, Brailoiu GC, Brailoiu E, et al. Distribution and biological activity of obestatin in the rat. J Endocrinol 2006; 191:481-489.
5. Mondal MS, Yamaguchi H, Date Y, et al. Neuropeptide Wis present in antral G cells of rat, mouse, and human stomach. J Endocrinol 2006; 188:49-57.
6. Chen D, Monstein HJ, Nylander AG, et al. Acute responses of rat stomach enterochromaffin-like cells to gastrin: secretory activation and adaptation. Gastroenterology 1994; 107:18-27.
7. Håkanson R, Ding XQ, Norlén P, Chen D. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 1995; 108:1445-1452.
8. Höcker M, John M, Anagnostopoulos J, et al. Molecular dissection of regulated secretory pathways in human gastric enterochromaffin- like cells: an immunohistochemical analysis. Histochem Cell Biol 1999; 112:205-214.
9. 2 nor muscarinic subtype 3 receptor knockout mice have altered differentiation of the parietal cells.
10. Cammisotto PG, Gingras D, Renaud C, et al. Secretion of soluble leptin receptors by exocrine and endocrine cells of the gastric mucosa. Am J Physiol Gastrointest Liver Physiol 2006; 290:G242-G249.
11. Spicer Z, Miller ML, Andringa A, et al. Stomachs of mice lacking the gastric H,K-ATPase alpha-subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J Biol Chem 2000; 275:21555-21565.
12. Roepke TK, Anantharam A, Kirchhoff P, et al. The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion. J Biol Chem 2006; 281:23740-23747. KCNE2 knockout mice are achlorhydric.
13. - exchanger are achlorhydric. J Biol Chem 2004; 279:30531-30539.
14. -/- mice. Am J Pathol 2006; 169:165-176. Ae2a, Aeb1 and Aeb2 isoforms in the parietal cells are responsible for stimulated acid secretion, while Ae2c accounts for basal acid secretion.
15. + exchanger. J Biol Chem 2005; 280:12781-12789.
16. 2 receptor-deficient mice. J Clin Invest 2000; 105:1741-1749.
17. 3 muscarinic receptor knockout mice. Gastroenterology 2003; 125:1774-1784.
18. Friis-Hansen L. Lessons from the gastrin knockout mice. Regul Pept 2007; 139:5-22.
19. Chen D, Zhao CM, Håkanson R, et al. Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice. Gastroenterology 2004; 126:476-487.
20. Langhans N, Rindi G, Chiu M, et al. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 1997; 112:280-286.
21. 2 receptor-deficient mice. Gastroenterology 2002; 123:577-585.
22. 2 and gastrin receptors in growth and differentiation of gastric mucosa. Eur J Pharmacol 2004; 502:243-252.
23. Tanaka S, Hamada K, Yamada N, et al. Gastric acid secretion in L-histidine decarboxylase-deficient mice. Gastroenterology 2002; 122:145-155.
24. Martinez V, Curi AP, Torkian B, et al. High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology 1998; 114:1125-1132.
25. 3 receptors in mouse stomach motility: studies with muscarinic receptor knockout mice. Eur J Pharmacol 2007; 554:212-222.
26. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003; 23:7973-7981.
27. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 2004; 101:4679-4684.
28. •,50]).
29. Tremblay F, Perreault M, Klaman LD, et al. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 2007; 148:501-506. There is no evidence for abnormal body weight or feeding behavior in GRP39 knockout mice.
30. Luque RM, Gahete MD, Hochgeschwender U, Kineman RD. Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. Am J Physiol Endocrinol Metab 2006; 291:E395-E403.
31. Ariyasu H, Takaya K, Iwakura H, et al. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 2005; 146:355-364.
32. Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett 2006; 238:15-29.
33. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109:113-124.
34. Yano T, Ito K, Fukamachi H, et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 2006; 26:4474-4488.
35. Lefebvre O, Chenard MP, Masson R. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274:259-262.
36. Yio X, Diamond M, Zhang JY, et al. Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 2006; 130:1696-1706.
37. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118:36-47.
38. Takaishi S, Wang TC. Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer. Cancer Sci 2007; 98:284-293.
39. Stenström B, Zhao CM, Rogers AB, et al. Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice. Carcinogenesis 2007; May 14 [Epub ahead of print].
40. Friis-Hansen L, Rieneck K, Nilsson HO, et al. Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology 2006; 131:246-258. Gastrin knockout mice have bacterial overgrowth in the stomach and display intestinal metaplasia, which may develop into cancer.
41. Tu S, Chi AL, Lim S, et al. Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1726-G1737.
42. Lopez-Diaz L, Hinkle KL, Jain RN, et al. Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol 2006; 290:G970-G979.
43. + channels'. Am J Physiol Cell Physiol 2004; 286:C478-C479.
44. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85:495-522.
45. Baynes KC, Dhillo WS, Bloom SR. Regulation of food intake by gastrointestinal hormones. Curr Opin Gastroenterol 2006; 22:626-631.
46. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117:13-23.
47. De Smet B, Depoortere I, Moechars D, et al. Energy homeostasis and gastric emptying in ghrelin knockout mice. J Pharmacol Exp Ther 2006; 316:431-439.
48. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310:996-999.
49. Gourcerol G, St-Pierre DH, Tache Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept 2007; 141:1-7. A large number of reports showing the lack of reproducible biological actions of obestatin on food intake raises the question whether obestatin will live up to its name as a peptide curtailing obesity.
50. Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007; 148:13-20.
51. Sun Y, Asnicar M, Saha PK, et al. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3:379-386. Mice deficient for both ghrelin and leptin still have the obese hyperphagic phenotype.
52. Zhu X, Cao Y, Voogd K, Steiner DF. On the processing of proghrelin to ghrelin. J Biol Chem 2006; 281:38867-38870.
53. Kopin AS, Mathes WF, McBride EW, et al. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 1999; 103:383-391.
54. Sakurai C, Ohta M, Kanai S, et al. Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient mice. J Physiol Sci 2006; 56:441-447.
55. Clerc P, Coll Constans MG, Lulka H, et al. Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology 2007; 148:1039-1049.